Neurobiological Technologies Stock Number Of Shares Shorted
Neurobiological Technologies fundamentals help investors to digest information that contributes to Neurobiological Technologies' financial success or failures. It also enables traders to predict the movement of Neurobiological Stock. The fundamental analysis module provides a way to measure Neurobiological Technologies' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Neurobiological Technologies stock.
Neurobiological |
Neurobiological Technologies Company Number Of Shares Shorted Analysis
Neurobiological Technologies' Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
More About Number Of Shares Shorted | All Equity Analysis
Shares Shorted | = | Shorted by Public | + | by Institutions |
Current Neurobiological Technologies Number Of Shares Shorted | 37.6 K |
Most of Neurobiological Technologies' fundamental indicators, such as Number Of Shares Shorted, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Neurobiological Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
CompetitionBased on the recorded statements, Neurobiological Technologies has 37.6 K of outstending shares currently sold short by investors. This is 98.82% lower than that of the Biotechnology sector and 99.26% lower than that of the Health Care industry. The number of shares shorted for all United States stocks is 99.2% higher than that of the company.
Did you try this?
Run Money Managers Now
Money ManagersScreen money managers from public funds and ETFs managed around the world |
All Next | Launch Module |
Neurobiological Fundamentals
Return On Equity | 1.0 | ||||
Profit Margin | 0.74 % | ||||
Operating Margin | 0.77 % | ||||
Current Valuation | (26.24 M) | ||||
Shares Outstanding | 27.02 M | ||||
Shares Owned By Institutions | 9.41 % | ||||
Number Of Shares Shorted | 37.6 K | ||||
Price To Book | 0.07 X | ||||
Price To Sales | 0.0004 X | ||||
Revenue | 6.03 M | ||||
Gross Profit | 26.35 M | ||||
EBITDA | 19.54 M | ||||
Net Income | 4.94 M | ||||
Cash And Equivalents | 26.49 M | ||||
Cash Per Share | 0.98 X | ||||
Book Value Per Share | 1.07 X | ||||
Cash Flow From Operations | 4.78 M | ||||
Short Ratio | 0.09 X | ||||
Target Price | 6.0 | ||||
Beta | -408.27 | ||||
Market Capitalization | 10.86 K | ||||
Total Asset | 2.58 M | ||||
Working Capital | (73 K) | ||||
Current Liabilities | 73 K | ||||
Z Score | 27.29 | ||||
Net Asset | 2.58 M |
Currently Active Assets on Macroaxis
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Consideration for investing in Neurobiological Stock
If you are still planning to invest in Neurobiological Technologies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Neurobiological Technologies' history and understand the potential risks before investing.
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Transaction History View history of all your transactions and understand their impact on performance | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume |